» Articles » PMID: 23255611

Type 10 Soluble Adenylyl Cyclase is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Dec 21
PMID 23255611
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

cAMP signaling plays an essential role in modulating the proliferation of different cell types, including cancer cells. Until now, the regulation of this pathway was restricted to the transmembrane class of adenylyl cyclases. In this study, significant overexpression of soluble adenylyl cyclase (sAC), an alternative source of cAMP, was found in human prostate carcinoma, and therefore, the contribution of this cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3. Suppression of sAC activity by treatment with the sAC-specific inhibitor KH7 or by sAC-specific knockdown mediated by siRNA or shRNA transfection prevented the proliferation of prostate carcinoma cells, led to lactate dehydrogenase release, and induced apoptosis. Cell cycle analysis revealed a significant rise in the G(2) phase population 12 h after sAC inhibition, which was accompanied by the down-regulation of cyclin B(1) and CDK1. sAC-dependent regulation of proliferation involves the EPAC/Rap1/B-Raf signaling pathway. In contrast, protein kinase A does not play a role. In conclusion, this study suggests a novel sAC-dependent signaling pathway that controls the proliferation of prostate carcinoma cells.

Citing Articles

Biochemical pharmacology of adenylyl cyclases in cancer.

Jena B, Flaherty D, OBrien V, Watts V Biochem Pharmacol. 2024; 228:116160.

PMID: 38522554 PMC: 11410551. DOI: 10.1016/j.bcp.2024.116160.


Quantifying and mathematical modelling of the influence of soluble adenylate cyclase on cell cycle in human endothelial cells with Bayesian inference.

Woranush W, Moskopp M, Noll T, Dieterich P J Cell Mol Med. 2022; 26(23):5887-5900.

PMID: 36372953 PMC: 9716222. DOI: 10.1111/jcmm.17611.


Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Guo R, Liu T, Shasaltaneh M, Wang X, Imani S, Wen Q Front Oncol. 2022; 12:829212.

PMID: 35832555 PMC: 9271773. DOI: 10.3389/fonc.2022.829212.


cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.

Ahmed M, Alghamdi A, Islam S, Lee J, Lee Y Cells. 2022; 11(13).

PMID: 35805104 PMC: 9266045. DOI: 10.3390/cells11132020.


Emerging Role of cAMP/AMPK Signaling.

Aslam M, Ladilov Y Cells. 2022; 11(2).

PMID: 35053423 PMC: 8774420. DOI: 10.3390/cells11020308.


References
1.
Wu K, Zippin J, Huron D, Kamenetsky M, Hengst U, Buck J . Soluble adenylyl cyclase is required for netrin-1 signaling in nerve growth cones. Nat Neurosci. 2006; 9(10):1257-64. PMC: 3081654. DOI: 10.1038/nn1767. View

2.
Hess K, Jones B, Marquez B, Chen Y, Ord T, Kamenetsky M . The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Dev Cell. 2005; 9(2):249-59. PMC: 3082461. DOI: 10.1016/j.devcel.2005.06.007. View

3.
Merkle D, Hoffmann R . Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor. Cell Signal. 2010; 23(3):507-15. DOI: 10.1016/j.cellsig.2010.08.017. View

4.
Chen Y, Cann M, Litvin T, Iourgenko V, Sinclair M, Levin L . Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science. 2000; 289(5479):625-8. DOI: 10.1126/science.289.5479.625. View

5.
Calebiro D, Nikolaev V, Gagliani M, de Filippis T, Dees C, Tacchetti C . Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 2009; 7(8):e1000172. PMC: 2718703. DOI: 10.1371/journal.pbio.1000172. View